TJX
43
3
SRE
52
2
AVY
53
3
MHK
46
3
PCAR
56
7
V
56
2
KMI
69
4
AVGO
32
7
HD
49
5
KSS
42
4
K
56
5
HRL
30
3
ETN
69
2
EMN
49
3
NDAQ
56
3
PNC
55
3
AEP
48
5
AA
47
4
NSC
53
6
PWR
66
7
TJX
43
3
SRE
52
2
AVY
53
3
MHK
46
3
PCAR
56
7
V
56
2
KMI
69
4
AVGO
32
7
HD
49
5
KSS
42
4
K
56
5
HRL
30
3
ETN
69
2
EMN
49
3
NDAQ
56
3
PNC
55
3
AEP
48
5
AA
47
4
NSC
53
6
PWR
66
7
Financhill
Back

AstraZeneca PLC 10K Form

Sell
32

AZN
AstraZeneca PLC

Last Price:
66.25
Seasonality Move:
-0.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AZN News And Ratings

See the #1 stock for the next 7 days that we like better than AZN

AZN Financial Statistics

Sales & Book Value

Annual Sales: $45.81B
Cash Flow: $2.42B
Price / Cash Flow: 29.72
Annual Sales: $12.74
Price / Book: 5.2

Profitability

EPS (TTM): 2.07000
Net Income (TTM): $6.44B
Gross Margin: $37.54B
Return on Equity: 16.87%
Return on Assets: 6.44%

AstraZeneca PLC Earnings Forecast

Key AstraZeneca PLC Financial Ratios

  • The Gross Profit Margin over the past 26 years for AZN is 81.95%.
  • The Selling, General & Administrative Expenses for AZN have been equal to 39.78% of Gross Profit Margin.
  • The Research & Development expenses have been 23.87% of Revenue.
  • The Interest Expense is 26.68% of Operating Income.
  • The Net Earning history of AZN is 13.00% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 20 years.

AstraZeneca PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AZN
CUSIP: 046353
Website: astrazeneca.com

Debt

Debt-to-Equity Ratio: 0.82
Current Ratio: 0.89
Quick Ratio: 0.69

Price-to-Earnings

Trailing P/E Ratio: 34.79
Forward P/E Ratio: 14.06

AZN Technical Analysis vs Fundamental Analysis

Sell
32
AstraZeneca PLC (AZN) is a Sell

Is AstraZeneca PLC a Buy or a Sell?

  • AstraZeneca PLC stock is rated a Sell
    The current AstraZeneca PLC [AZN] share price is $66.27. The Score for AZN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.